HHS Finalizes OBBBA Marketplace Rules: Six Actuarial Repricing Triggers for 2027

HHS's final rule implementing the One Big Beautiful Bill Act eliminates automatic marketplace reenrollment, shortens open enrollment to five weeks, and narrows special enrollment periods across plan years 2027 and 2028, each provision filtering healthier, price-sensitive enrollees out of a risk pool insurers say already carries roughly 4 percentage points of subsidy-expiry morbidity load from 2026 (KFF, July 2026).

From reviewing ACA bid certifications through the 2017 cost-sharing-reduction disruption and the 2026 subsidy cliff, each eligibility provision that filters enrollment at the margin has historically added 1 to 4 percentage points of morbidity loading depending on the price elasticity of the affected cohort, and the effects compound across provisions applied at once rather than adding linearly. HHS's Notice of Benefit and Payment Parameters for 2027, finalized in stages through the first half of 2026 and consolidated with the OBBBA implementation rule package, gives 2027 bid actuaries six such provisions to price in a single cycle. Preliminary 2027 filings from 77 insurers across 16 states and the District of Columbia already show a median proposed increase of 14%, with a quarter of filers requesting more than 21% and none proposing a decrease (KFF, July 2026). The question this article answers is not whether OBBBA raises 2027 premiums; every filing already assumes that. It is how an actuary should decompose the increase into six discrete, quantifiable triggers rather than a single undifferentiated policy load.

What HHS Finalized, and When

CMS Administrator Dr. Mehmet Oz framed the rule package around eligibility integrity: "American taxpayers deserve to know their dollars are going only to people who truly qualify" (CMS, 2026). Beneath that framing sits a two-track implementation schedule actuaries need to track separately, because the 2027 and 2028 provisions carry different morbidity timing.

For plan year 2027, effective with open enrollment beginning November 1, 2026, HHS shortens the federal open enrollment window from November 1 through January 15 to November 1 through December 15, a five-week compression, and bars state-based marketplaces from extending enrollment past December 31 (CMS, 2026). The same 2027 rule eliminates the ongoing special enrollment period for consumers below 150% of the federal poverty level, a provision that had let low-income enrollees sign up in any month rather than only during open enrollment or after a qualifying life event. For plan year 2028, Section 71303 of OBBBA ends automatic reenrollment entirely for subsidy-eligible marketplace consumers: unless an enrollee actively confirms eligibility and plan selection each fall, coverage and premium tax credits lapse rather than carry forward. A transitional mechanism previewed the incentive structure for 2026 coverage, requiring auto-reenrolled $0-premium enrollees to pay $5 per month until they actively confirmed their information, though that piece was stayed before implementation (AMA, 2026). HHS's own regulatory impact analysis estimates the rule package will reduce marketplace enrollment by up to 2 million people in 2027, with an additional 1 million leaving each year through 2030 (CMS, 2026).

Trigger One: Auto-Reenrollment Elimination and the Passive-Enrollee Subsidy

Automatic reenrollment functions as an invisible cross-subsidy inside every marketplace risk pool, and removing it removes that subsidy along with the enrollees who relied on it. Passive reenrollees, people who take no action and are simply carried into next year's coverage by the exchange, skew younger and lower-utilization than active shoppers for a specific behavioral reason: engaged, high-utilization enrollees have a standing incentive to actively compare plans each fall to optimize provider networks and drug formularies around ongoing care, while healthy enrollees have no such incentive and are the ones most likely to let a renewal happen automatically. When reenrollment stops being automatic, the friction of an active renewal falls disproportionately on that healthy, disengaged segment, and the segment most likely to complete the renewal step is the one already managing a chronic condition.

The actuarial estimate for this effect depends on an input carriers can measure directly from their own book: passive reenrollment share, the percentage of a carrier's prior-year membership that was auto-reenrolled rather than actively re-shopping. A book with a high passive share, common among carriers with strong retention and minimal rate movement, has more to lose from the provision than a book where most members already re-shop annually. Applying a 1 to 3 percentage point morbidity load range to the passive-reenrollment segment specifically, rather than to the full book, is the calibration step that keeps this trigger from being either overstated or ignored. A carrier with 40% passive reenrollment share and a 2-point load on that segment prices roughly 0.8 percentage points of book-wide morbidity from this trigger alone; a carrier with 65% passive share and the same per-segment load prices 1.3 points. The provision phases in for 2028 coverage, which means 2027 bids should reflect anticipatory behavior, brokers and navigators warning members the safety net is ending, rather than the full effect, and 2028 bids should reflect the full realized shift.

Trigger Two: A Five-Week Shorter Open Enrollment Window

Compressing open enrollment from eleven weeks to six changes who completes the signup process, not just when. Behavioral patterns in enrollment deadlines consistently show procrastination-driven signups clustering in the final two to three weeks of any window, and those late signups skew toward acute need, someone who just received a diagnosis, started a new medication, or scheduled a procedure and realized coverage was needed before the window closes. A shorter window compresses that same late-decision behavior into fewer available days, and the marginal enrollee lost to the shorter window is disproportionately the one who would have signed up in early-to-mid January under the old deadline: still comparison shopping, price-sensitive, and not yet facing an acute health event. December 15 also lands five weeks earlier than the prior January 15 cutoff, before many consumers have received a final December paycheck or squared away holiday-season budgets, both factors the Urban Institute's review of the 2026 enrollment cliff correlated with delayed marketplace shopping among lower-income households (Urban Institute, December 2025).

The pricing implication is a shift in enrollee mix under the same lapse-rate framework used for the auto-reenrollment trigger, but with a different demographic signature: the shortened-window effect concentrates among price-sensitive shoppers who were never on the books to begin with, rather than among existing passive reenrollees. That distinction should be reflected in how a carrier documents the load in a rate filing: double-counting the same lost enrollee under both triggers overstates the combined effect. The two should be modeled against distinct populations, existing passive reenrollees for trigger one and new or re-shopping enrollees for trigger two, not blended into a single undifferentiated factor.

Trigger Three: Narrowed Special Enrollment Periods

Eliminating the below-150%-FPL special enrollment period removes a pathway that let the lowest-income enrollees, who face the smallest net premium after subsidies, sign up in any month rather than waiting for the annual window or a qualifying life event. That population is disproportionately healthy relative to enrollees who use SEPs tied to a qualifying event such as job loss or a new diagnosis, because a $0 or near-$0 premium plan available year-round attracts opportunistic, low-engagement signups from people who are not managing an active health condition. Removing the monthly on-ramp for this subsidy tier does not remove eligibility, but it removes the low-friction pathway that made enrollment likely, and the added friction falls hardest on the segment with the least reason to push through it.

HHS's own actuarial modeling of the 2025 predecessor rule, which layered in SEP pre-enrollment verification requirements ahead of the 2027 low-income SEP elimination, projected roughly 293,000 SEP-related verification issues and an associated premium decline of up to 1% market-wide from the combined effect of tighter SEP administration (Health Affairs Forefront, 2025). That 1% figure is a market-average effect across all SEP types combined; a health actuary building a 2027 bid should not apply it uniformly, because low-income SEP elimination is a larger, more concentrated effect on any book with above-average low-income enrollment than the same 1% applied to a book skewed toward higher-FPL, employer-adjacent membership.

Trigger Four: Risk Adjustment's Interaction With a Market-Wide Morbidity Shift

The ACA's HHS-HCC risk adjustment formula transfers funds among carriers within a state market based on relative risk, and it is revenue-neutral by construction: the sum of all transfers nets to zero. That structural feature is precisely why risk adjustment does not neutralize a market-wide morbidity shift the way it neutralizes a carrier-specific one. If every carrier in a market loses the same healthier-enrollee segment to the same OBBBA provisions in roughly the same proportion, relative risk scores across carriers barely move, transfers stay roughly where they were, and the entire market-wide cost increase flows through as unhedged premium trend rather than a risk-adjustment-mediated wash. A carrier that loses a larger-than-market share of its passive reenrollees or SEP-eligible enrollees, because its specific membership skewed more toward those segments, will see its relative risk score rise faster than the market average and will receive a larger transfer receivable, but that receivable compensates for being worse-affected than peers, not for the market-wide shift itself.

This is the mechanism trade press coverage of OBBBA consistently omits: risk adjustment protects an individual carrier from bearing more than its proportional share of a market-wide morbidity increase, but it does not protect the market, or any individual carrier, from the increase itself. A carrier modeling its 2027 risk adjustment receivable using the same formula-behavior assumptions that applied in a stable-enrollment year will overstate the offset, because the formula's compensating power depends on cross-carrier variance in who lost enrollees, and OBBBA's provisions apply market-wide rather than to any single carrier's book.

Trigger Five: The 2026 Baseline Problem

Every 2027 bid actuary is extrapolating forward from 2026 claims experience, and that baseline is already compromised in a specific, quantifiable way. Wakely Consulting Group's analysis of January 2026 effectuated enrollment, built from a dataset representing roughly 80% of the individual market, found that enrollees who paid their January premium carried, on aggregate, 10% higher morbidity than enrollees who did not pay and were consequently never effectuated (Wakely, April 2026). Wakely's broader 2026 morbidity estimate, incorporating both the effectuation gap and the underlying subsidy-driven lapse pattern, put the year's morbidity increase in a range of 2.9% to 6.5%, with effectuated enrollment down an estimated 17% to 26% from 2025 levels depending on state (Wakely, April 2026). KFF's independent read of the same dynamic, drawn from insurer rate filing narratives rather than claims data, converged on a similar order of magnitude: insurers attributed roughly 4 percentage points of the 2026 premium increase to risk pool deterioration from subsidy expiry, on top of a 21.7% headline premium increase from 2025 to 2026 that dwarfed the 2.0% average annual growth insurers had filed for between 2020 and 2025 (Urban Institute, December 2025; KFF, July 2026).

The baseline problem compounds rather than adds. An actuary who takes 2026 claims experience, already elevated by the 2.9% to 6.5% Wakely morbidity shift, and then applies a fresh OBBBA-attributable load on top using a pre-2026 reference point double-counts the portion of the OBBBA effect that already materialized inside the 2026 baseline through anticipatory enrollment behavior. The defensible approach separates 2026 experience into its already-realized subsidy-expiry component and prices the incremental 2027 provisions, auto-reenrollment anticipation, the shortened window, and the narrowed SEPs, as a distinct, smaller increment layered on top of an already-elevated base, rather than treating 2027 as a fresh application of the full 4-percentage-point-style load KFF's insurers cited for 2026.

Trigger Six: State Exchange Variance

OBBBA's marketplace provisions apply nominally market-wide, but implementation timing and interpretation vary by exchange type in ways that create a genuinely multi-regime pricing environment rather than a single national effect. HHS's final rule requires all state-based marketplaces to cap open enrollment at December 31, but leaves each SBM free to set its own start-to-close window inside that ceiling, meaning a state-based exchange could run a longer window than the federal marketplace's November 1 to December 15 schedule as long as it closes by year-end (CMS, 2026). States operating their own exchanges have historically retained more enrollees through disruption events than states on the federal platform; Wakely's 2026 analysis found state-based exchanges experienced less enrollment disruption and effectuation loss than federally-facilitated exchange states during the same subsidy-expiry period (Wakely, April 2026), a pattern consistent with state-based exchanges' greater flexibility on outreach, navigator funding, and locally-tailored enrollment assistance.

For a carrier operating across multiple states, or a multi-state actuarial team building a single national methodology memo, the state exchange variance trigger means the other five triggers cannot be applied with one national load factor. A carrier writing business in a state-based exchange that elects a longer within-ceiling open enrollment window, or that delays low-income SEP elimination pending its own rulemaking, should apply a smaller load for triggers two and three in that state than in a federally-facilitated exchange state implementing the rule on HHS's default timeline. Tracking implementation status by state before applying a uniform morbidity load is the difference between a defensible state-specific rate filing and a national average that is wrong in every state it is applied to.

The Six Triggers Summarized

Trigger	Primary effective year	Directional load indicator	Source
1. Auto-reenrollment elimination	2028 (anticipatory in 2027)	1–3 pp on the passive-reenrollment segment	OBBBA Sec. 71303 / CMS, 2026
2. Shortened open enrollment window	2027	Component of KFF's ~4 pp 2027 morbidity estimate	KFF, July 2026
3. Narrowed SEPs (150% FPL elimination)	2027	Up to 1% market-wide (SEP administration bundle)	Health Affairs Forefront, 2025
4. Risk adjustment non-neutralization	2027 ongoing	No automatic offset for market-wide shifts	ACA risk adjustment methodology
5. 2026 baseline compounding	2027 (baseline year 2026)	2.9%–6.5% already embedded in claims baseline	Wakely, April 2026
6. State exchange variance	2027, state-dependent	Multiplier on triggers 1–3, varies by SBM vs. FFE	CMS / Wakely, 2026

The 2028 Compound Effect

Treating 2027 as a one-time shock, rather than the first of two compounding provisions, is the most common error actuarial commentary on OBBBA has made so far. Trigger one, auto-reenrollment elimination, is scheduled for full effect in plan year 2028, which means the 2027 rate year absorbs only the anticipatory portion of that trigger. State defrayal requirements for non-EHB mandated benefits also begin in 2028 rather than 2027, a one-year delay HHS built in specifically because states needed more time to secure appropriations (CMS, 2026). A 2027 rate filing that fully prices trigger one as though already at steady state overstates the 2027 load and will show favorable actual-to-expected experience relative to that assumption; a 2027 filing that ignores trigger one because its statutory effective date is 2028 will be caught flat-footed when the 2028 filing needs a full-magnitude load on top of whatever residual adverse selection remains from 2027's other five triggers.

The parallel to the 2017 to 2019 cost-sharing-reduction disruption is instructive but incomplete. That disruption resolved over two to three years, not one, and the eventual moderation came as much from carrier exits concentrating the remaining pool as from genuine risk pool improvement. OBBBA's provisions differ structurally: they are permanent statutory and regulatory changes, not a one-time funding interruption, so there is no analogous mean-reversion to build into a 2028 or 2029 projection. A rate filing that explicitly acknowledges the 2027-to-2028 trajectory, showing the actuary's basis for splitting the six triggers' effects across the two rate years rather than loading everything into 2027 or deferring everything to 2028, is the more defensible filing under regulatory review.

What This Means for 2027 Bid Development

The six-trigger framework converts OBBBA from an undifferentiated policy headwind into six separately estimable, separately documentable line items, each with its own effective date, its own affected population, and its own interaction with risk adjustment. Carriers that instead apply a single blended morbidity load, calibrated only to KFF's roughly 4-percentage-point 2027 aggregate estimate, are borrowing a market-average figure that will not match their specific book's exposure to passive reenrollment share, SEP-eligible enrollment concentration, or state exchange implementation timing. The 14% median premium increase insurers have already filed for 2027 reflects medical trend running at 10% against an 8% historical average, subsidy-expiry morbidity continuing at roughly the same order of magnitude as 2026, and some portion of these six OBBBA-specific triggers, but preliminary filings submitted before the July 2026 deadline were built against a final rule still being finalized in stages through the first half of the year (KFF, July 2026).

Actuaries should expect regulators in several states to request supplemental filings or rate justification amendments once the full rule package's effective dates and state-level implementation choices are confirmed. Building the six-trigger decomposition now, before that supplemental request arrives, is the difference between a rate filing that can answer a regulator's question with a specific number and one that has to reconstruct the analysis under deadline pressure.

Sources